Maggioli Group Takes 20% Stake in Clinical AI Startup DatAIMed
aiinsider ·
The Maggioli Group has acquired a 20% stake in DatAIMed, a Turin-based clinical AI startup, through a €1.2 million capital increase. Founded by Dario Taborelli, DatAIMed offers an evidence-based artificial intelligence platform designed for clinical knowledge and continuing medical education within Europe. The system allows healthcare professionals to query international biomedical literature and institutional references using natural language, receiving concise summaries linked to verifiable sources. It integrates data from entities such as the European Medicines Agency and Italy’s AIFA, while also supporting internal hospital protocols. By centralizing scattered information, the platform aims to reduce research time for doctors and support better-informed clinical decisions. All infrastructure and data are hosted within the EU to ensure GDPR compliance and prevent customer data from training models. Despite facing a crowded market of healthcare AI competitors, DatAIMed seeks to differentiate itself through its rigorous evidence-based approach and regulatory adherence.
aiinsider